title: Small molecule modulators of HIV Rev/Rev response element interaction identified by random screening.
abstract: A high throughput scintillation proximity assay with biotinylated human immunodeficiency virus (HIV) Rev protein and tritiated Rev response element RNA was used to screen over 500,000 small molecules. Several chemical classes of inhibitors and two chemical classes of enhancers of binding were identified, with the molecular weight range being 400-600. The most common structural motif of inhibitor was an acidic moiety at the end of a linear aromatic system. Most of these modulators had EC(50) values in the 1-10 microM potency range, with several below 1 microM. Several classes displayed structure-activity relationships suggesting specific molecular interactions between small molecule and macromolecule. Several molecules were confirmed as inhibitors in a gel shift assay and by surface plasmon resonance analysis. Furthermore, one inhibitor was shown to bind the Rev protein with a binding constant equal to its IC(50) value, consistent with the mechanism of inhibition being binding Rev. Thus, small molecules can modulate this macromolecular protein-RNA interaction in vitro. However, no compound demonstrated HIV antiviral activity in a relevant cell-based assay.
authors.affiliation: Department of Molecular Screening, GlaxoSmithKline, PO Box 1-3398, Research Triangle Park, NC 27709-3398, USA.
authors.forename: Richard L
authors.initials: RL
authors.lastname: Chapman
authors.forename: Thomas B
authors.initials: TB
authors.lastname: Stanley
authors.forename: Richard
authors.initials: R
authors.lastname: Hazen
authors.forename: Edward P
authors.initials: EP
authors.lastname: Garvey
mesh_terms: D000595:Amino Acid Sequence; D000998:Antiviral Agents / Q000302:isolation & purification / Q000378:metabolism / Q000494:pharmacology*; D001667:Binding, Competitive / Q000187:drug effects; D024202:Electrophoretic Mobility Shift Assay; D015694:Gene Products, rev / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D015752:Genes, env / Q000187:drug effects / Q000502:physiology*; D006678:HIV / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D020128:Inhibitory Concentration 50; D008969:Molecular Sequence Data; D012367:RNA, Viral / Q000235:genetics / Q000378:metabolism*; D012588:Scintillation Counting; D013329:Structure-Activity Relationship; D020349:Surface Plasmon Resonance; D054321:rev Gene Products, Human Immunodeficiency Virus
chemical_list: D000998:Antiviral Agents; D015694:Gene Products, rev; D012367:RNA, Viral; D054321:rev Gene Products, Human Immunodeficiency Virus